Targeted tumor therapy with the TGF-beta 2 antisense compound AP 12009.
Schlingensiepen KH, Schlingensiepen R, Steinbrecher A, Hau P, Bogdahn U, Fischer-Blass B, Jachimczak P.
Schlingensiepen KH, et al. Among authors: schlingensiepen r.
Cytokine Growth Factor Rev. 2006 Feb-Apr;17(1-2):129-39. doi: 10.1016/j.cytogfr.2005.09.002. Epub 2005 Dec 27.
Cytokine Growth Factor Rev. 2006.
PMID: 16377233
Review.